|

Blood Collection Biorepository for Liver Disease Research

RECRUITINGSponsored by State University of New York at Buffalo
Actively Recruiting
SponsorState University of New York at Buffalo
Started2013-07
Est. completion2099-12
Eligibility
Age7 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03025074

Summary

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Eligibility

Age: 7 Years+Healthy volunteers accepted
Inclusion Criteria:

* This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
* Children and teenagers will be special populations considered in this protocol.

Exclusion Criteria:

* Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.

Conditions9

Bariatric Surgery CandidateCirrhosisFatty LiverFibrosisHepatitis BHepatitis CLiver DiseaseNon-Alcoholic Steatohepatitis (NASH)Obesity, Childhood

Locations1 site

University at Buffalo, Buffalo General Medical Center
Buffalo, New York, 14203
Barbara Bauer, BA716-888-4825bmbauer@buffalo.edu

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.